Multiple Drug Use Clinical Trial
Official title:
Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention 2
Verified date | March 2024 |
Source | Arizona State University |
Contact | YiYuan Tang |
Phone | 4807903577 |
yiyuan[@]asu.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.
Status | Recruiting |
Enrollment | 35 |
Est. completion date | August 31, 2026 |
Est. primary completion date | August 31, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - At least 18 years old - Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis) - In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month - Normal or corrected-to-normal vision - Written informed consent - No previous meditation or NF experiences Exclusion Criteria: - Any psychiatric diagnoses other than an SUD - Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females) - Excluding cannabis, evidence of recent (past month) illicit drug use |
Country | Name | City | State |
---|---|---|---|
United States | YiYuan Tang | Phoenix | Arizona |
Lead Sponsor | Collaborator |
---|---|
Arizona State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intervention effects on brain function using Functional Magnetic Resonance Imaging (fMRI) | Brain connectivity changes such as anterior and posterior cingulate cortex measured by fMRI resting state imaging | The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months | |
Primary | Intervention effects on brain white matter using fMRI | Brain white matter changes such as anterior and posterior cingulate cortex measured by fMRI diffusion tensor imaging | The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months | |
Primary | Intervention effects on brain grey matter using fMRI | Brain volume changes such as anterior and posterior cingulate cortex measured by fMRI structural imaging | The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months | |
Secondary | Intervention effects on addiction behavior using substance use questionnaires in PhenX Toolkit | Intervention leads to a significant reduction in craving and substance use measured by substance use questionnaires in PhenX Toolkit | The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06214130 -
Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets
|
Phase 1 | |
Completed |
NCT01689493 -
Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation
|
N/A | |
Recruiting |
NCT01758679 -
A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma
|
Phase 4 | |
Completed |
NCT04261504 -
Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention
|
N/A |